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1. Introduction 
The treatment of angina pectoris as an important symptom of coronary artery disease is 
usually focused on restoring the balance between myocardial oxygen demand and supply 
by administration of drugs interfering in heart rate, preload, afterload, and coronary 
vascular tone. For non responders to drug therapy or for those with jeopardized 
myocardium, revascularization procedures such as coronary artery bypass graft surgery 
(CABG) and percutaneous transluminal coronary angioplasty (PTCA) are at hand. 
However, these therapies cannot stop the disease process and, at longer terms, angina may 
recur. It is not always possible to revascularize all the patients who do not sufficiently react 
to medical treatment. In these group patients alternative therapies are more effective. A 
major difference between alternative therapies versus traditional therapies is that alternative 
therapy tends to look at the entire patient rather than simply treating a disorder as 
traditional treatments do. Some kinds of these therapies are applicable in all patients with 
coronary artery disease irrespective of their symptoms and the other ones would be 
considered in patients with refractory angina who are not suitable for revascularization. 
2. General alternative therapy 
These therapies are applicable in all patients with coronary artery disease whether they are 
symptomatic or not. 
2.1 Heart healthy lifestyle 
2.1.1 Goals                 
Preventing heart disease, living heart healthy, and overcoming stress-related heart illness 
requires more than just a physical approach to heart problems. Whether or not patients had 
an interventional angioplasty or bypass surgery, it's obvious that some changes in lifestyle 
will need to be made. To continue living a normal active life, one needs to begin making 
heart healthy lifestyle changes that include eating a heart healthy diet. Maintaining a 
healthy diet and lifestyle offers the greatest potential of all known approaches for reducing 
the risk for CVD in the general public. Specific goals are to consume an overall healthy diet; 
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aim for a healthy body weight; recommended levels of low-density lipoprotein cholesterol, 
high-density lipoprotein cholesterol, and triglycerides; normal blood pressure; normal blood 
glucose level; be physically active and avoid use of and exposure to tobacco products. 
Consume a Healthy Diet: 
An emphasis on whole diet should be done to ensure nutrient adequacy and energy balance. 
Hence, rather than focusing on a single nutrient or food, individuals should aim to improve 
their whole or overall diet. (1) The American Heart Association has provided dietary 
recommendations and recommendations for an overall healthy lifestyle to the American 
public with the goal of reducing risk for cardiovascular diseases. (1) 
Achievement or maintaining an ideal body weight: 
A healthy body weight is currently defined as a body mass index (BMI) of 18.5 to 24.9 
kg/m2. Overweight is a BMI between 25 and 29.9 kg/m2, and obesity is a BMI 30 kg/m2. 
Achieving and maintaining a healthy weight throughout life is particularly difficult and are 
critical factors in reducing CVD risk in the general public. Great emphasis should be put on 
prevention of weight gain (2), because achievement and maintenance of weight loss, 
although certainly possible, require more difficult behavioral changes ie, greater calorie 
reduction and more physical activity, than prevention of weight gain in the first place. 
Prevention of excess weight gain:  
Prevention of excess weight gain relies on the maintenance of energy balance, whereby 
energy intake equals energy consumption over the long term.(1, 2) This means maintaining 
a relatively stable weight across life stages. A positive imbalance will increase energy 
storage, deposited as body fat and observed as weight gain. Although the concept is 
seemingly simple, the physiological systems that regulate body weight through energy 
intake and consumption mechanisms are complex, interactive, homeostatic, and still poorly 
understood. Furthermore, the components of energy balance are not weighed easily or with 
adequate precision to be practical as a guide to help individuals maintain energy balance. In 
theory, a small persistent energy imbalance of 50 kcal per day could result in a 5-lb weight 
gain in 1 year, provided that all other things being equal. (2)                 
Treatment of obesity: 
Although prevention and treatment of obesity both depends on the same principles of 
energy balance, the application of the principles is completely different. For treatment of 
obesity, a large reduction in calorie intake of about 500 to 1000 kcal per day, along with 
increased physical activity, can result in a loss of approximately 8- 10% of body weight over 
the relatively short period of about 6 months. Although the types of low-calorie diets that 
best promote weight loss are the subject of current investigations, behaviors for weight loss 
focused on caloric reduction such as decreasing overall food intake, reducing portion sizes, 
substituting lower-calorie for higher calorie foods, and increasing physical activity. Weight 
loss is best achieved by participation in a behavioral program using self-monitoring, goal-
setting, and problem-solving techniques. Motivation levels may be high for appearance 
reasons or if adverse health consequences and quality of life impairments associated with 
obesity are readily perceived.(2) However, because weight regain after weight loss is 
common, motivations and strategies to maintain weight may differ largely from those 
initiating weight loss.(2) 
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A diet rich in vegetables and fruits: 
Most vegetables and fruits are rich in nutrients, low in calories, and high in fiber. Diets high 
in fiber, especially from cereal sources, substantially reduce the risk of coronary heart 
disease. Short-term randomized trials have shown that diets rich in vegetables and fruits not 
only provide micronutrient, macronutrient, and fiber requirements, but also lower BP and 
improve other CVD risk factors. Vegetables and fruits that are deeply colored, for example, 
spinach, carrots, peaches and berries, ought to be emphasized because they tend to be 
higher in micronutrient contents compared to other vegetables and fruits such as potatoes 
and corn. Equally important is the method of preparation which includes techniques 
preserving nutrient and fiber content without adding unnecessary calories, saturated or 
trans fat, sugar, and salt.(1) 
2.2 Supplements 
It is ideal to get the body nutritional needs in foods .When that is not enough, a registered 
dietitian may also start a series of supplements to make up for nutrients not getting through 
the diet. Some of the more popular supplements for both healthy and those at risk for 
coronary artery disease include antioxidants such as vitamins C and E, B-complex, omega-3 
fish oil and coenzyme Q10. The American Heart Association recommends 2-4 grams of 
Omega-3 per day for anyone with high triglycerides and at least 1 gram per day for anyone 
with documented coronary heart disease. (1) According to the results of  many clinical trials 
performed to clear the role of dietary supplements in the prevention and /or slowing the 
progression of cardiovascular diseases , the long-term effects of most dietary supplements 
other than for vitamins and minerals are not known, so these agents should be prescribed 
under professional supervision of physician or a registered dietitian. 
Essential Fatty Acids 
Omega-3 and Flaxseed oil 
Flaxseed oil comes from the seeds of the flax plant (Linum usitatissimum, L.) which 
contains both omega-3 and omega-6 fatty acids, which are vital for health. They are 
composed of essential fatty acid alpha-linolenic acid (ALA), which the body turns into 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the omega-3 fatty acids 
found in fish oil. Some researchers argue that flaxseed oil might have some of the same 
usefulness as fish oil, but the body is not very efficient at converting ALA into EPA and 
DHA, however, the benefits of ALA, EPA, and DHA are not necessarily the same. The 
human body is not able to make its own omega-3 fatty acids, so it is important that they are 
part of everyone’s dietary intake. (3) The consumption of 2 servings (8 ounces) per week of 
fish high in EPA and DHA can result in a reduction of risk of mortality and morbidity from 
coronary artery disease. In addition to providing EPA and DHA, regular fish consumption 
may facilitate the displacement of other foods higher in saturated and trans fatty acids from 
the diet, such as fatty meats and full-fat dairy products.(1) Omega-3 fatty acids seem to have 
a small, dose-dependent, hypotensive effect, the extent of which seems to be dependent on 
the degree of hypertension.(4) In a meta-analysis, Morris et al found a significant reduction 
in blood pressure of ≤ 3.4/ 2.0 mmHg in studies with hypertensive subjects who consumed 
5.6 g/d of omega-3 fatty acids.(4) Likewise, Appel et al found that blood pressure was 
decreased ≤ 5.5/ 3.5 mmHg in trials of untreated hypertensives given 3 g/d of omega-3 fatty 
acids. DHA seems to be more effective than EPA in lowering blood pressure. (4) Getting a 
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good balance of omega 3 and 6 fatty acids in the diet is important which are examples of 
polyunsaturated fatty acids (PUFAs).  Omega 3 fatty acids help reduce inflammation, while 
most omega 6 fatty acids tend to contribute to inflammation. A healthy diet should consist 
of roughly 2 to 4 times fewer omega 6 fatty acids than omega 3 fatty acids.  Some species of 
fish may contain significant levels of methylmercury, polychlorinated biphenyls (PCBs), 
dioxins, and other environmental contaminants which is a potential concern for using 
them.(1,4) Subgroups of the population, primarily children and pregnant women are 
advised by the FDA to avoid eating those fish with the potential for the highest level of 
mercury contamination. Eating up to 12 ounces (2 average meals) per week of a variety of 
fish and shellfish that are lower in mercury is also recommended. (1) The American Heart 
Association recommends inclusion of omega 3 fatty acids in patients with stable CAD 
because of evidence from randomized controlled trials. The recommended daily dose in 
patients with stable coronary artery disease is 1 gram of eicosapentaenoic 
acid/docosahexaenoic acid (EPA/DHA) by capsule supplement, the equivalent amount in 
alpha-linolenic acid (LNA) from vegetable source, or by eating daily fatty fish(1). Since 
maintaining daily fish meals can be difficult, capsule supplements may be preferred 
although there is no uniformity of EPA/DHA content or purity. 
Niacin 
Niacin (nicotinic acid) is a B vitamin that has been used in high doses (1.0–4.5 grams per 
day) as a treatment for hyperlipidemia which is associated with increased risk of CAD. 
Niacin reduces cholesterol and TG levels, and increases the concentration of high-density 
lipoprotein (HDL). (5) It is also effective at modulating blood lipids, but side effects 
sometimes dampen enthusiasm for therapy. Although side effects are dose-related, few 
studies have determined an optimal dose of nicotinic acid that alters lipid levels with the 
fewest side effects. Martin-Jadraque et al. (6) found improvement in blood lipid levels in 
75% of subjects who tolerated low-dose nicotinic acid therapy. Nicotinic acid may also be 
useful in combination drug therapy for prevention of CAD if higher doses cannot be 
tolerated. Use of a lower dose should still be beneficial for producing a moderate rise in 
HDL levels. Women seem to have a greater LDL response to niacin, but experience more 
side effects at higher dosages. (7) 
Long-term treatment with nicotinic acid (4 g/day for 6 weeks) not only corrects serum 
lipoprotein abnormalities, but also reduces the fibrinogen concentration in plasma and 
stimulates fibrinolysis. (8) Although most medications used to treat dyslipidemias will raise 
HDL levels modestly; however, niacin appears to have the greatest potential to do so, 
increasing HDL up to 30%. (9)  
Vitamin C 
A widely publicized study showed that men who took 800 mg daily of vitamin C lived 
about 6 years longer than those consuming of 60 mg per day. (10) A study of elderly 
subjects; being supplemented by vitamin C and vitamin E to subjects using no vitamin 
supplements showed that use of vitamin E alone reduced death from myocardial infarction 
(MI) by 63% and overall mortality by 34%. When the vitamin C and E were used together, 
overall mortality was reduced by 42%. (11) 
A proper supply of nutrients will allow the cellular damage to vascular walls to be repaired 
properly and prevent further cracks and lesions. The results of a clinical studies, published 
in the Journal of Applied Nutrition (12), determine the effect of a nutritional supplement 
program, consisting of vitamin C therapy, on the natural progression of coronary artery 
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disease. The study used Ultrafast Computed Tomography to document the level of coronary 
artery disease and the sample of patients composed of people with early and advanced 
stages of the disease. During the course of the 12-month study, the rate of coronary artery 
calcification decreased in all patients by an average of 15%. In the subset of early stage 
patients, the progression of calcification was stopped completely. In some cases, calcification 
was actually reversed, including a case of the disappearance of all calcification deposits.  
Vitamin E 
Evidence demonstrates that vitamin E protects against development of atherosclerosis by 
reducing oxidation of LDL, inhibiting proliferation of 4smooth muscle cells, decreasing 
platelet adhesion and aggregation, and changing the expression and function of adhesion 
molecules. The biological functions of vitamin E (attenuating the synthesis of leukotrienes 
and potentiating release of prostacyclin) which reduces platelet aggregation and acts as a 
vasodilator may protect against the development of atherosclerosis. (13) 
A large study that examined the relationship between the intake of dietary carotene, vitamin 
C, and vitamin E and subsequent coronary mortality found an inverse association between 
dietary vitamin E and coronary mortality, supporting the hypothesis that antioxidant 
vitamins provide protection against CAD. (14) Large epidemiological studies revealed that 
higher vitamin E levels in plasma result in a reduced incidence of CAD. Dose-response 
studies in humans have demonstrated that 400 IU per day of vitamin E increased vitamin E 
plasma levels twofold and delayed oxidation of LDL, while the length of time was more 
important than the amount of the nutrient used. (15) The type and blend of vitamin E 
selected for supplementation can affect the end results. Studies show that -tocopherol may 
offer better protection against CAD when it is combined with gamma tocopherol, which has 
a greater activity. Unfortunately, gamma tocopherol is poorly retained in body because it is 
excreted in urine following liver metabolism, whilst -tocopherol is more abundant in body 
tissues which does not provide for maximum protection against free radical attack. So 
complexing -tocopherol (80%) with gamma tocopherol (20%) is an ideal blend for 
individuals seeking protective cardiovascular effects from vitamin E tocopherol. 
Coenzyme Q10 
Coenzyme Q10 (CoQ10; ubiquinone) is a fat-soluble cofactor substance. It is a naturally 
occurring substance that prevents cell damage due to myocardial ischemia (hypoxia) or 
subsequent to reestablishment of blood flow to the heart after temporary ischemia. 
CoQ10 is involved in several key enzymes in energy production within a cell, and has 
membrane-stabilizing activity. Numerous studies provide details of the efficacy of CoQ10 in 
the prevention and treatment of heart disease, as detailed below. Oral CoQ10 (150 mg daily 
in 3 doses) was given for 4 weeks to exercising angina patients. Average levels of CoQ10 in 
plasma increased after CoQ10 treatment and were significantly related to an increase in 
exercise duration. The study suggested that: "CoQ10 is a safe and promising treatment for 
angina pectoris". (16) Pretreatment with intravenous CoQ10 minimized myocardial injury 
caused by cardiac bypass graft (CABG) surgery and improved heart function. In patients 
undergoing CABG pretreatment with intravenous CoQ10 (5 mg/kg, intravenously 2 hours 
before cardiopulmonary bypass) prevents left ventricular depression in early reperfusion 
and minimizes myocardial cellular injury during CABG following reperfusion. (17) 
In comparison with younger individuals, the outcome of surgery in the elderly, is 
compromised by age-related reduction of cellular energy production in the myocardium 
during surgery. Fibers from subjects over age 70 showed poor recovery of force after 
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simulated ischemia compared to younger patients. This age-associated effect was prevented 
by pretreatment with CoQ10 (18), in addition CoQ10 pretreatment prior to stress improved 
recovery of the myocardium after stress (19). Because of the popular use of "statin" drugs 
(Zocor, Lipitor, Pravachol, Lescol, and Mevacor) it is important to emphasize that statins act by 
inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis. Drugs 
inhibiting HMG-CoA reductase activity decrease CoQ10 levels (20) because HMG-CoA 
reductase is required for CoQ10 synthesis. Individuals using statins ought to increase their 
intake of CoQ10 to negate the decrease in CoQ10 biosynthesis caused by the statin drugs. So it 
is recommended to administer it with statin therapy. CoQ10 is free of toxicity and typically 
produces no side effects and may change the insulin requirements of people with diabetes. 
2.3 Mind-body relaxation techniques  
While living a type A lifestyle isn't typically categorized as a main risk factor for heart disease, 
learning how to deal with life and lower stress levels can help down road to recovery.  
Mind-body approach aimed at diminishing excess activation in the nervous system and 
thereby improving one's own ability to modulate emotional and behavioral responses. 
Relaxation therapy is a broad term used to describe a number of techniques that promote 
stress reduction, the elimination of tension throughout the body, and a calm and peaceful 
state of mind. 
Relaxation techniques include behavioral therapeutic approaches that differ widely in 
philosophy, methodology, and practice. There are two basic methods, deep methods include 
autogenic training, progressive muscle relaxation, and meditation (although meditation is 
sometimes distinguished from relaxation based on the state of "thoughtless awareness" that 
occurs during meditation). Brief methods include self-control relaxation, paced respiration, 
and deep breathing. Brief methods generally are less time consuming and often represent a 
summarized form of a deep method. In order to be able to evoke the relaxation, several 
months of practice (at least three times per week) is required. 
Some of the more popular relaxation techniques include massage therapy, yoga, listening to 
music, pray and meditation.  
Massage therapy 
Massage therapy is the scientific manipulation of the soft tissues of the body, consisting 
primarily of manual (hands-on) techniques such as applying fixed or movable pressure, 
holding, and moving muscles and body tissues. 
Various forms of therapeutic superficial tissue manipulation have been practiced for 
thousands of years across cultures. Chinese use of massage dates to 1600 BC, and 
Hippocrates made reference to the importance of physicians being experienced with 
"rubbing" as early as 400 BC. There are references to massage in ancient records of the 
Chinese, Japanese, Arabic, Egyptian, Indian, Greek, and Roman nations. Many different 
therapeutic techniques can be classified as massage therapy. Most involve the application of 
fixed or moving pressure or manipulation of the muscles/connective tissues of clients. 
Practitioners may use their hands or other areas such as forearms, elbows, or feet. Used 
techniques during massage therapy include (1) superficial stroking away from the heart or 
deep stroking towards the heart; (2) kneading in a circular pattern using fingers and 
thumbs; (3) deep muscle stimulation; (4) rhythmic movements such as slapping or tapping; 
and (5) vibration. Scientific research of massage is limited, and existing studies use a variety 
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of techniques and trial designs. Firm evidence-based conclusions about the effectiveness of 
massage cannot be drawn at this time for any health condition. 
Shiatsu 
Shiatsu literally means ‘finger pressure’. Shiatsu is based on the same principles as 
acupuncture concentrating on meridians or energy lines but without the needles. Everything 
is related to the five elements that correspond to different parts of the body:  
Heart: Fire, Kidney: Water, Spleen: Earth, Lungs: Metal, Liver: Wood.  
The idea, as in acupuncture, is to balance the life energy in the body which is disturbed 
when we become ill. Through a series of finger pressures all over the body along the specific 
pathways, Shiatsu can rebalance the body’s energies, regulate the organs’ function and 
improve circulation. Shiatsu  last up to 1 hour during which practitioners often use their 
elbows, knees and feet as well as their fingers for palpation of the abdomen and other areas 
which may be lacking energy , but they seldom use the hands’ palms unlike other 
traditional Western contact therapies.  
Yoga 
The term “Yoga” comes from a Sanskrit word meaning "union." Yoga combines physical 
exercises, mental meditation, and breathing techniques to strengthen the muscles and 
relieve stress.The first known work is "The Yoga Sutras," written more than 2,000 years ago, 
although yoga may have been practiced up to 5,000 years ago. Yoga has been described as 
"the union of mind, body, and spirit," which addresses physical, mental, intellectual, 
emotional, and spiritual dimensions towards an overall harmonious state of being. It works 
towards self-realization and control of mental, physiological, and psychological parameters. 
Yoga is often practiced by healthy individuals with the aim to achieve relaxation, fitness, 
and a healthy lifestyle. Yoga has also been recommended and used for a variety of medical 
conditions and consists 30 to 90 minutes sessions.  
Meditation  
Meditation is usually suggested as a stress management technique used to cause a tranquil 
and relaxed state of mind. However, researchers have lately found that meditation offers 
other significant health benefits by changing deeper and more dynamic processes in the 
body, even so far as being able to strengthen the heart. Researchers at the Margaret and H.A. 
Rey Laboratory, Boston, USA discovered that meditation impacts prominent heart rate 
variability traditionally associated with practicing slow breathing during specific traditional 
forms of Chinese Yoga meditation techniques. (21) The magnitude of this variability during 
meditation was much far greater than when compared to those not practicing any 
meditation in healthy young adults and even elite athletes during sleep. These results 
uncovered that meditation can have a profound effect on the heart and its activity. The 
researchers observed that the variability of beat-to-beat heart rate was directly affected by 
meditation. The report concluded that meditation should not be seen as just a method of 
relaxation and stress management, but also as an aid to strengthen the heart and create a 
more active state in the body.(21) 
2.4 Cardiac rehabilitation and exercise training   
I. Cardiac rehabilitation definition  
Cardiac rehabilitation (CR) is welcomed not only as integral in the management of patients 
with coronary artery disease, but also as the primary means in delivering secondary 
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prevention which consists of a number of activities or measures that may be adapted by 
patients so as to reduce the symptoms or the risk of a further event. 
More recently CR has been redefined as follows: “Cardiac rehabilitation is the process by 
which patients with cardiac disease, in partnership with a multidisciplinary team of health 
professionals, are encouraged and supported to achieve and maintain optimal physical and 
psychosocial health”. (22,23)  
According to guidelines, CR including exercise training, patient education, psychological 
support, risk factor management, and clinical assessment, is indicated for patients with 
ischemic heart disease (IHD), chronic heart failure,  patients with a high risk for developing 
IHD (24-27), patients with valvular heart diseases, cardiac transplantation, Implanted 
cardioverter defibrillators, and congenital heart diseases (23). 
II. Cardiac rehabilitation phases 
Cardiac rehabilitation is divided into four phases, ranging from the acute hospital admission 
stage to long-term maintenance of lifestyle changes, as follows (23,25,26): 
Phase I (in patient period): is started after a ‘step change’ in cardiac condition including 
myocardial infarction, onset of angina, any emergency hospital admission for coronary heart 
disease, cardiac surgery or angioplasty and/or stenting, and first diagnosis of heart failure. 
This should begin as soon as possible after admission.  Phase I consists of  assessment, 
education, exercise/mobilization. 
Phase II (Early post-discharge): exercise consultation and behavior change strategies are 
benefecial at this stage to improve adherence to both lifestyle change and maintenance of 
exercise in phase II and uptake of phase III in the future. This is the stage for risk factors 
modification and goal setting in phase I (lasting over a period of between 8 and 12 weeks).  
Phase III (supervised out-patient): at this stage, risk factor changes and education are 
continued. Phase III is usually consists of at least two supervised exercise sessions per week, 
lasting over a period of between 6 and 12 weeks. Patients may be provided with one session 
of education per week. Physical training is often the essential part of phase III, while 
psycho-social counseling and education considering risk factors and lifestyle are of primary 
importance. In addition to the aerobic conditioning phase, resistance training is part of CR 
exercise. Home-based exercise is also prescribed with self monitoring skills being used by 
the patients. 
Phase IV (long-term maintenance of exercise and other lifestyle changes): For the benefits of 
physical activity and lifestyle change to be sustained, the available evidence suggests that 
both are necessary to be retained.  As clinically indicated, referral to specialist clinicians, 
such as smoking cessation or psychological support, may still be needed. Continuation and 
progression of appropriate physical activities are persuaded outside the hospital setting. By 
this time it is looked forward that individuals will be aware of their exercise capabilities and 
be able to monitor themselves properly. 
III. Cardiac rehabilitation and exercise training in Ischemia  
There are several mechanisms by which regular exercise training exercise training may 
improve myocardial oxygen supply and thereby result in an anti ischemic effect. Exercise 
training reduces cardiac workload at a given (sub maximal) exercise level by improved 
adaptation of the peripheral circulation. A alternative external work can be gained with a 
lower heart rate and blood pressure, thereby reducing myocardial oxygen demands and 
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coronary blood flow requirements in areas with a potentially critical perfusion deficit.  Since 
myocardial perfusion is related to the length of the diastole, the time for perfusion of the 
myocardium decreases with increasing heart rate. Thus, exercise training improves the 
economy of the heart work and facilitates myocardial perfusion in patients with coronary 
artery stenoses. A lower heart rate and a lower systolic blood pressure during exercise is a 
usual though somewhat transient phenomenon after exercise training in normal persons as 
well as in patients with CAD. To maintain this training effect exercise needs to be 
incorporated into the daily routine – such as medication. (22, 25)  Many studies have 
revealed that the symptomatic improvement as a result of exercise training is mainly owing 
to a decrease in the rate–pressure product at sub maximal workloads with no change in the 
rate–pressure product at the onset of angina (22, 28) Later reports also showed a rise in the 
rate–pressure product at the onset of angina along with a reduction in the ischemic response 
measured as angina or ST-segment depression, at a given rate–pressure product, suggesting 
that exercise training improves myocardial oxygen delivery. There are controversial aspects 
about improvement in angiographic collateralization or regression of coronary 
atherosclerosis- that might be a reason for less ischemia- despite the endurance exercise 
training program. However, some surveys showed a significant tendency toward decreasing 
progression after prolonged rather intense, particularly in those patients who took part 
more sessions of the structured training program (22,29,30). 
The question whether ischemia should be avoided during endurance training in stable 
patients is open to question. The studies of Ehsani et al. suggest that in selected patients 
significant ST-segment depression can be borne without adverse effects (31). However, for 
safety reasons it is usually recommended to avoid ischemia during endurance training in 
order to minimize risks and maximize benefits. In patients with symptoms suggesting 
instability, exercise is not recommended until the phase of instability has resolved. (32) 
Randomized clinical trials (RCTs) and meta-analyses have demonstrated significant (14% to 
24%) relative reductions in all-cause mortality over 1 to 2 years in patients with coronary 
artery disease randomized to cardiac rehabilitation programs. Women, elderly patients, low-
income groups, and ethnic minorities tend to be under-represented in RCTs. (33 - 35) CR 
also resulted in a comparable effects in terms of cardiac overall survival, event-free survival 
and other secondary outcome measures like cardiac morbidity. (36,37)  Stukel et al argued 
whether the true size of the effect is 10% or 30%, but both are large when translated into 
absolute population numbers .(38)  
The effects of Cardiac rehabilitation on Endothelial function 
One of the positive effects of exercise is the improvement of endothelial dysfunction. 
Endothelial dysfunction is a precursor of clinically significant atherosclerotic disease and is 
a signal for an increased cardiovascular event rate.(39-41)  
Different efforts have been made to correct the impaired endothelium-dependent 
vasodilatation. In recent years it has become apparent that exercise affects the functional 
activity of the vascular endothelium.Whereas normal coronary arteries dilate, atherosclerotic 
coronary arteries often exhibit a paradoxical vasoconstriction in response to exercise, thereby 
causing critical ischemia even in moderate epicardial stenosis. Endothelium-derived NO is the 
main mediator of improved endothelial function and enforces a multitude of anti 
atherosclerotic functions. Acting on the endothelial cell itself, NO inhibits endothelial cell 
apoptosis, suppresses inflammatory activation, and increases the activity of oxygen radical-
scavenging enzymes. Furthermore NO inhibits platelet aggregation via luminal release from 
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the endothelium and also inhibits vascular smooth muscle cell proliferation and promotion 
of positive arterial remodeling. Studies using cultured endothelial cells and animal 
experiments suggest that increases in endothelial NO synthesis expression and protein 
phosphorylation are possible mechanisms. Exercise training in stable CAD leads to an 
improved agonist-mediated endothelium-dependent vasodilatory capacity. (42-45)  Exercise 
training induces adaptations in cellular mechanisms of nitric oxide regulation in collateral-
dependent coronary arteries of chronically occluded vessels that contribute to enhanced 
nitric oxide production (46). Also arterial production of reactive oxygen species could 
significantly reduced by exercise training.  
Improvement in Exercise Capacity 
Physical activity is seen as a behavior that generally has advantages on exercise capacity and 
many of the physiologic processes involved in the development of primary prevention of 
coronary artery disease. (26) Lavie et al reported a 34% improvement in exercise capacity 
after cardiac rehabilitation participation. (47) Some newer studies showed every one MET 
increase in exercise capacity can induce more than 17% improvement in survival rate, it is 
especially important in heart failure patients .(25,26) 
Improvement in Left Ventricular Function (systolic and diastolic) 
Ehsani et al studied 25 patients, 52 (±2) years old with coronary artery disease and mildly 
impaired LV function (ejection fraction 53%)[31], They compared these to 14 patients with 
comparable maximal exercise capacities and ejection fractions who did not undergo an 
exercise training program. The exercise group completed a 12- month program of very 
intense endurance exercise training of progressively increasing intensity, frequency, and 
duration. Ejection fraction did not change during maximal supine exercise before training 
(52 ± 3%),but after training it increased during exercise to 58 ±3% (P<0.01), despite a higher 
rate–pressure product during maximal exercise, providing some evidence for an 
improvement in contractile state after training – or also for improved perfusion with less 
ischemic impairment of myocardial function during exercise. (22,31)                            
In one of the first small prospective studies of endurance training in HF patients, Sullivan et 
al confirmed that 4 to 6 months of training did not deteriorate LV ejection fraction and 
tended to improve maximal cardiac output. (48) Another larger randomized clinical trial 
provided evidence for a training- induced reverse remodeling with modest improvements 
of LVEF and reductions of LV end-diastolic diameter in a mixed population of ischemic and 
dilated cardiomyopathy.(49)     
Heart failure with preserved left ventricular ejection fraction (HFPEF) is the most popular 
form of HF in the older population. Exercise intolerance is the primary chronic symptom in 
patients with HFPEF and is a strong determinant of their reduced quality of life (QOL). 
Exercise training improves exercise intolerance and diastolic function and QOL in patients 
with HF with preserved and reduced ejection fraction. (50)   
Improvement of quality of life      
Cardiac rehabilitation is increasingly known as an integral part of comprehensive cardiac 
care. The evidence supporting its effectiveness in reducing morbidity and mortality and 
improving quality of life (51) Frank suggested that those who have greater physical 
functionality, the confidence to perform physical activities, and are not restricted clinically, 
may more readily adjust to cardiac rehabilitation and progress more rapidly. Those patients 
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with the poorest exercise capacities at entrance to the program tended to make the greatest 
gains in health related quality of life. (52)  
Improvement in risk factors profile 
Regular physical activity is associated with favorable modification of cardiovascular risk 
factors such as hypercholesterolemia, hypertension, diabetes, and obesity. (22,53-57)  
Cost- benefit 
Cardiac rehabilitation is one of the most effective treatments of secondary prevention for 
patients with heart disease. These standard training programs are safe and cost-effective. (37) 
IV. Cardiac rehabilitation components 
IV.a Exercise program 
Not only a universal understanding of patient’s medical history, current status, and 
medication regimen need to be taken into account, while prescribing an exercise, but also a 
solid understanding of exercise physiology as relates to recreational and vocational 
activities. Experience and individualization of exercise prescription are essential for optimal 
success in activity programming. A staged exercise test (preferably Ramp protocols) is 
recommended for exercise prescription. Every activity program should be consist of a 
warm-up, conditioning, and cool-down periods. (25,58)      
Warm up:  is a 5 to 15 minutes period, during which the musculature and joint structures 
are stimulated gently with a series of static stretches and dynamic range of motion (ROM) 
activities. A large group of muscle is involved in the warm-up stretches. The stretch should 
be maintained 15-30 seconds and should not result in discomfort or pain. Patients should be 
encouraged to continue to breathe to avoid Valsalva maneuver that can cause exaggerated 
BP responses. 
Conditioning period: The conditioning period may be designed to focus on the following 
activities: 
1. To increase caloric expenditure to aid with weight management 
2. To improve overall functional capacity 
3. To delay the onset of symptom 
4. To improve muscle tone and strength 
5. To optimize job or vocational abilities 
6. To optimize recreational activity performance 
7. To optimize ability to perform activities of daily living (ADL) 
It must address 5 keys factors: Frequency, Intensity, Mode, Duration, Rate of progression  
Frequency: Typically, the exercise stimulus must be done at least three times per week. It is 
recommended that the sessions be allocated equally throughout the week. From an FC 
improvement standpoint, there is trivial achievement by extending the program beyond 5 
days per week. It is recommended that the average rehabilitation program being with an 
exercise frequency of 3 times per week for at least the first 3-6 months, if after this time the 
patient has remained free of musculoskeletal complications and expresses an interest in 
increasing the frequency, the program can reach to four to five times per week. 
Intensity: According to ACSM guideline the intensity threshold for healthy adults is 
between 60-90% of HR max in a staged exercise test or 50-85% of Vo2max or heart rate 
reserve (HRR).The typical range of exercise intensity for patients involved in cardiac 
rehabilitation is between 40% and 85%. Exercise intensity is not static. The cost of the 
activities varies slightly from day to day, depending on the time of day, environmental 
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factors, and time since medications were last taken. Medications, especially ǃ-blockers, can 
alter the patient’s FC significantly. If significant stable ischemic changes or symptoms occur 
with activity, the exercise intensity must be established at a level adequately below the 
threshold for these findings (usually 10-15 beat/min below the onset of ischemic changes). 
If possible, to minimize any flaw in prescribing exercise intensity, it is advised to carry out 
the exercise test for exercise prescription on all usual medications and the same approximate 
time of day as patients exercise.  
Mode: Any activity that ingages a mass of muscle group in a rhythmic and repetitive fashion 
(dynamic exercises) at the approximate intensity and duration leads to improved FC. The most 
common sorts of the activity used in CR are walking and appropriate jogging. Cycling, 
swimming, rowing, stair climbing, and aerobic dancing are other popular activities used in CR 
programs. Recent studies, however, have demonstrated the safety and benefit  
of isotonic and weight training programs. Strengthening is recommended 2-3 times per week. 
Duration: The duration of conditioning period is typically 15 and 60 minutes. A minimum 
of 15 minutes is necessary to achieve an improvement in FC. The optimal duration is 20-40 
minutes. It can be extended if the intensity is reduced and a goal of the program is increased 
caloric consumptions. Patients with significant claudication, low FC, or marked weakness 
may require an interval program (limited by symptoms), until the total time of all intervals 
equals the prescribed duration.  
Rate of progression: The first scale developed by Borg ranges from 6 to 20 and is linear, 
with word anchors that describe the exercise intensity equally spaced along the length of the 
scale. On average, a perceived exertion of 12 to 14(somewhat hard), on the 6 to 20 scale, 
corresponds with a HR response of between 60% and 85%, respectively. The second scale 
has an exponential design to the spacing of the word anchors and runs from 0 to 10. For 
ratings on the 10 point scale; values between 3 and 6 correspond to a similar HR response. 
Cool- down: this period should promptly follow the conditioning period in an activity 
session. It lasts 3-10 minutes. The patients should perform low- level, rhythmic, aerobic 
activities during period. After the active aerobic cool- down, static stretching and fine ROM 
activity included again. Stretching exercises are essential segment in each training session. 
IV.b Education 
Patient education can play an integral role in acomplishment of any CR program, provided 
that it is done properly. The inclusion of the patient education program changes, depending 
on the background of the patient and on the phase of CR. Some topics which should be 
taken into consideration are the following: management of risk factors through lifestyle 
modifications of smoking, diet, stress management and exercise behavior; return to work; 
medications; sexual activity; exercise prescription and psychological issue.  
IV.c Psychological consideration and stress management 
Depression: The relationship between depression and CAD is well atated. Depression is 
highly prevalent in cardiac patients, and is a considerable risk factor for cardiac outcomes. 
Patients should be screened for depression at entry to CR programs, using either a few 
verbal screening questions or a standardized depression questionnaire. Depressed patients 
enrolled in CR programs will need more attention to insure continued adherence and close 
monitoring to rapidly intervene provided that depressive symptoms worsen. (22,23,25,59) 
Several treatments have shown some success in treating depression in cardiac patients, 
including antidepressant medication (sertraline), psychological interventions (such as 
www.intechopen.com
 
Alternative Non-Medical, Non-Surgical Therapies for the Treatment of Angina Pectoris 
 
171 
cognitive behavioral therapy), and exercise training. Other psychological disorders such as 
type A personality behavior, anger and hostility should be managed in CR setting. (23, 25, 
26) Treatment with cardiac rehabilitation can improve mental health related quality of life in 
a significant way. (60)  
Stress management: The previous researches has indicated that mental and emotional stress 
can result in myocardial ischemia and is associated with a several fold increase in 
occurrence of subsequent fatal, and nonfatal, cardiac events. Although the efficacy research 
on stress management in cardiac rehabilitation is fraught with methodological issues, it 
appears that psychological interventions that are successful in reducing distress are also 
successful in reducing morbidity and mortality. Key components for providing sufficient 
stress management interventions include envolving patients through joining the process of 
heart disease to their own experiences, assissting them to understand the ability they have 
in slowing or reversing the process through the choices they make in dealing with 
responses, providing adequate training and opportunities for guided practice in producing 
the relaxation response, and teaching patients to shift perceptions and beliefs that tend to 
increase stress and effect healthy coping.  
Relaxation Training: Relaxation training has also been found to reduce heart rate, 
respiratory rate and muscle   tension. The patients can take advantage of relaxation training 
that instructs them to use abdominal breathing and visual imagery to focus attention on 
healing stimuli, memories, or fantasies.  
V. Home- based cardiac rehabilitation 
Home-based secondary prevention programs for CAD are an effective and fairly low-cost 
alternative measure to hospital-based CR and should be noticed for stable patients unlikely 
to access or adhere to hospital-based services.(61,62)  
VI. Safety of exercise training 
In the meanwhile, the benefits of comprehensive cardiac rehabilitation have been obviously 
demonstrated, but the exercise training-induced complications and benefit-risk ratio of 
cardiac rehabilitation remains poorly understood. Screening procedures can be used to 
identify subjects at increased risk for an exercise-related cardiac event. These are patients 
who are generally at increased risk of sudden cardiac death; particularly patients with 
severe LV dysfunction or ischemia at low levels of exercise. The results of studies reporting 
the risks of sudden cardiac arrest during exercise training depict that this risk is low even 
during vigorous exercise. These studies strongly suggest that the incidence of sudden 
cardiac arrest across a variety of activities, with the exception of jogging, is similar to that 
expected by chance alone. In summary, the risk of cardiac events during exercise testing and 
training appears to be very low, but such events seem difficult to for see. Finally, although 
risk stratification remains necessary at the beginning of a CR program, the occurrence of a 
severe cardiac event seems to be difficult to predict in most cases. This difficulty emphasizes 
the role of the cardiologist in the prescription and supervision of CR sessions. (63-66) 
VII. Problems exist in cardiac rehabilitation 
Underutilization of cardiac rehabilitation  
Unfortunately despite the obvious benefits and effectiveness of CR on quality of life and 
mortality, and regardless of the class I indication from AHA/ACC (67-69), the majority of 
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people who would benefit from this program fails to participate in it and right now the main 
present problem with exercise-based cardiac rehabilitation is its underutilization. (37,70,71)  
Barrier to cardiac rehabilitation 
There are multiple interrelated factors that influence a patient’s decision to use cardiac 
rehabilitation services. These factors divided into environmental and individual categories. 
(72) The healthcare delivery systems and policies within hospitals and cardiac rehabilitation 
programs represent factors within the internal environment. These factors are amenable to 
improvement. The external environment which includes factors that affect the patient’s 
ability to use healthcare services are not as amenable to change, such as where they reside or 
their access to these services. Individual factors (at the patient and provider level) are 
composed of 4 categories. 1) Predisposing factors are socio-demographic characteristics and 
prior experiences with cardiac rehabilitation. 2) Enabling factors are any skill or resource 
required to enroll and participate regularly (income, social support, work/personal schedules, 
transportation, knowledge, attitude, and beliefs). 3) Reinforcing factors strengthen or lessen 
the motivation for program attendance and adherence (strength of physician endorsement, 
encouragement and support of healthcare providers, family, and friends). 4) Need factors in 
term of physician’s and patient’s perceptions are influenced by the clinical condition, 
psychological factors, and anticipated benefits of the service. Many of the barriers that arise 
from these categories provide opportunities for healthcare professionals to attempt to improve 
rates of CR referral, registration, and completion. (72-79) 
3. Specific alternative therapy 
Treatment of patients with refractory angina pectoris has still remained challenging in 
patients with end-stage coronary artery disease not suitable for revascularization (even 
bypass surgery or angioplasty with stent).    
3.1 ESMR (Extracorporeal Shockwave Myocardial Revascularization) 
Extracor Extracorporeal Shock Wave Therapy (ESWT) was introduced in the early 1990s as a 
spin-off of urological lithotripsy.(80) Since then, ESWT has been applied to treat various 
musculoskeletal conditions. Right now Shockwave Myocardial Revascularization (ESMR) is 
a breakthrough in management of refractory angina pectoris with end-stage coronary artery 
disease not suitable for revascularization (81). The treatment is performed using a special 
generator that produces low intensity shockwaves, a kind of sound waves similar to, but of 
lower strength than Extracorporeal Shock Wave Lithotripsy (ESWL) that is used in the 
treatment of kidney stones . These acoustic shock waves are not dissolving plaque in the 
same way that lithotripsy breaks up a stone, instead, these waves result in release 
substances which stimulate the formation of new blood vessels in the heart.( 82) The shock 
wave schedule consists of three 20-minute sessions per week over nine weeks.  
The patient must first undergo cardiac SPECT (single photon emission computed 
tomography) testing to identify the location of the ischemic areas. Afterwards a handheld 
device called a transducer is placed over the skin and shockwaves will then be delivered 
directly to the ischemic region under echocardiographic guidance. (83)The therapy sessions 
that have already been conducted have yielded positive results among treated patients who 
claim they have had their pain alleviated since the beginning of the treatment. ESMR is an 
alternative therapy for patients who have angina, even though they take medicine, and are 
not suitable candidates for coronary angioplasty or bypass surgery. 
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3.2 EECP (Extracorporeal Electrical Counter pulsation) 
EECP is sometimes known as a "natural bypass" since it optimizes the body's ability to 
develop new vessels around stenotic arteries. EECP seems to be a noninvasive, well-
tolerated therapeutic option for patients with coronary artery disease (CAD) and refractory 
angina who are not amenable to standard revascularization procedures. (84-86)The EECP 
device consists of three paired pneumatic cuffs applied to the lower extremities. Patients are 
typically treated for 1 hour daily program for a total of 35 sessions over 7 weeks. The cuffs 
are inflated in sequence, placing pressure on the legs which pushes blood flow from the 
lower limbs up towards the heart. The inflation of the cuffs occurs during diastole so it 
increases blood flow delivery to the heart at the precise moment it is relaxing. Then, just 
before the heart pumps, the cuffs deflate, reducing resistance and decreasing the heart's 
workload.  
Prospective clinical trials and large treatment registries have shown major reductions in 
anginal symptoms and improvements in objective measures of myocardial ischemia in 
response to EECP in patients with symptomatic CAD. Its potential role in heart failure 
management, which improves quality of life and reduces symptoms, has been also 
shown.(84)  
EECP treatment is associated with an immediate increase in blood flow in multiple vascular 
beds including the coronary artery circulation and causes acute changes in hemodynamics 
including an increase in preload and a decrease in afterload.(87-90) Several published 
studies were designed to assess objective evidence of improvement in myocardial perfusion 
and beneficial hemodynamic effects. They have also shown improvements in various organ 
system perfusions and LV diastolic filling after EECP treatment and it is even recommended 
as initial revascularization treatment for refractory angina. The abrupt drop in intra-aortic 
pressure unloads the left ventricle during systole, thus reducing the cardiac workload in 
ejection period and reducing myocardial oxygen demands.  
EECP greatly accelerates the formation of collateral vessels, helping restore adequate 
circulation to organs and tissues that have been deprived of blood and oxygen. EECP was 
developed at Harvard University almost 50 years ago as a therapy for angina. Several 
studies have shown that patients who undergo a course of EECP experience fewer episodes 
of angina, experience less intense episodes of angina, need less anti-angina medication, can 
walk farther without experiencing angina, and resume work and enjoy more social 
activities.(86, 91) 
In a recent study by Esmaeilzadeh et.al, the effects of EECP on regional myocardial function 
were evaluated. Given their findings, EECP can improve global and regional LV systolic and 
diastolic functions by means of strain and strain rate imaging.(91)  
Unlike drugs that are prescribed for angina, EECP is completely safe and without side 
effects. And unlike angioplasty and bypass surgery, EECP can be done on an outpatient 
basis and requires no post-treatment recovery period. Patients suffering a heart attack or 
enduring one or even several surgeries for coronary artery disease are best candidates for 
this kind of treatment. In some cases, EECP is their only option. Yet this noninvasive 
therapy is so safe and effective that it should be considered as a first-line treatment for 
angina, not just a last resort after surgery has been ruled out.  
For a growing number of patients, who are imposed a potentially dangerous surgical 
procedure, recommending EECP is a wise decision; because in less time than it takes to 
recover from bypass surgery, these patients can complete a full course of EECP and begin 
enjoying an active, pain-free life.  
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3.3 Neurostimulation 
For the first time healing power of electric current was described by Scribonius Largus, the 
physician of the Roman emperor Claudius, in the treatment of headache and gout.(92)  
Because of the very promising results of neurostimulation in different ischemic syndromes, 
it seemed obvious to try electrical neurostimulation therapy as an adjuvant therapy in 
patients suffering from medically refractory angina pectoris. The beneficial effects of 
transcutaneous electrical nerve stimulation (TENS) were described by Mannheimer and 
colleagues. (93,94)  
For patients not responding to adequate medication and not being suitable anymore for 
revascularization and suffering from refractory angina pectoris, neurostimulation has been 
described repeatedly as an effective and safe therapy.(95,96) The mechanism of action of 
neurostimulation is not completely known, however, recent studies suggest that anti-
ischemic effect expressed by decrease in the serum catecholamine level, exerted by reducing 
sympathetic tone. (97-99) 
The effect of TENS on coronary flow was not accomplished in patients with a heart 
transplant which suggests that neurostimulation employs its effect through neural 
mechanisms employed at the microcirculatory level. (100)   Considering the lack of resting 
heart rate and blood pressure variability under neurostimulation, it’s unlikely that beta-
adrenergic mechanisms are involved. (101) Moreover, beta-mediated coronary dilatation is 
of less importance in the ischemic myocardium. (102)  On the other hand, alpha- adrenergic 
receptors may play a role in the anti-ischemic mechanism of action of neurostimulation. 
Inhibition of the alpha receptors may cause relative vasodilation at the subendocardial 
coronary level,(103) which in turn may cause a redistribution effect. 
At present it is unknown which neural pathways are involved in neurostimulation for 
angina pectoris. It is discovered that angina begins with stimulation of cardiac nerve 
endings.(104,105) by visceral afferent nerve fibers, converging in common pathways into the 
dorsal spinal cord at C7-T5 level, where they have synaptic connections with other 
neurons.(106) Afferent fibers from the heart and cutaneous input are assumed to cover 
specific interneurons in the same segment of the spinal cord, explaining the ensuing referred 
projection of pain to the related dermatome.(107, 108) Consequently, angina is felt in areas 
of the chest that refer to the dermatome from which afferent nerves project to the same 
segment of the spinal cord (C7-T5) as the heart. For an optimal clinical result of 
neurostimulation it is of great importance to achieve paresthesia in the same dermal regions.  
Although there is increasing evidence that neurostimulation is effective in angina pectoris, 
its safety needs to be established. In a 5-year follow-up study of 23 patients on spinal cord 
stimulation (SCS), Sanderson reported that it is a safe therapy based on the fact that; 
(109) only three patients died during this follow-up. In another follow up study, out of 46 
patients with severe coronary artery disease who were treated at the Groningen University 
Hospital Department of Cardiology with SCS; only six patients died during a7- year  
period. (110) 
However, despite declining mortality rates in patients with coronary artery disease, little is 
known about mortality rates in patients with refractory angina due to severe coronary artery 
disease. It is estimated that 3% (about 7 million) of Americans have active coronary artery 
disease implying an annual death rate of 7 %. (111)  
Another important issue which needs further attention before the general acceptance of 
neurostimulation as an alternative therapy in angina pectoris is its complication rate. 
Because of the high skin impedance, TENS is frequently complicated by persistent skin 
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irritation, which makes adequate continuation of therapy difficult. Meanwhile, SCS has a 
rather high incidence of dislocation of the epidural lead,(112) and this often impairs its 
effect. 
Once the safety of neurostimulation in angina pectoris is convincingly established and the 
aforementioned side effects can be further reduced, both TENS and SCS may be 
commonly used as alternatives in the therapeutic spectrum of intractable angina pectoris. 
3.4 Acupuncture 
Acupuncture involves the insertion of extremely thin needles in skin at strategic points of 
body. Acupuncture originated in China six thousands of years ago, but during the past three 
decades it was grown significantly as a popular therapy within the world. 
It works by stimulating the body to naturally correct the imbalances of energy. This is done 
by inserting ultra-fine, disposable needles, underneath the skin at specific points of the 
body. (113) These acupuncture points are related to energy pathways that run throughout 
the entire length of the body. Acupuncture points are also related to specific internal organs. 
The earliest known text on acupuncture was published more than 4,500 years ago. 
Acupuncture has been traditionally used to treat a wide variety of cardiovascular diseases, 
and recent controlled studies have demonstrated that it is particularly beneficial for angina 
pectoris by offering a proven option to drug therapy. 
Traditional Chinese theory explains acupuncture as a technique for balancing the flow of 
energy through specific pathways (meridians) in the body. In contrast, many Western 
practitioners believe the acupuncture points as places to stimulate nerves, muscles and 
connective tissue. This stimulation seems to boost the activity of natural painkillers and 
increase blood flow. (114)  
Basically, acupuncture is a method of encouraging the body to enhance its own natural 
healing. The idea is to balance overall energy in order to establish or re-establish well-being. 
Research has shown that the body response to acupuncture is releasing endorphins 
(neurotransmitters that stop pain), increasing blood cell counts, and heightening the 
immune system. Acupuncture is used worldwide both as a primary and complementary 
form of medical treatment. The frequency of treatment depends greatly on the condition. 
Most people will begin to see results from acupuncture in approximately 4-10 treatments. 
Treatments are generally administered once per week until improvement is made and then 
follow-up appointments may range from a few times per year to monthly to bi-weekly.  
In one study (115) at the Human College of Traditional Chinese Medicine, forty patients 
with stable type of angina pectoris were assessed during and after acupuncture treatments 
and compared to a control group. After only one acupuncture treatment, 15 (37.5%) of the 
patients were already noticing a marked improvement in degree and area of pain, but after 7 
treatments 25 (63%) of the patients recorded significant reductions both in extent and area of 
pain, and they also experienced a reduction in the number and the duration of attacks. 
Furthermore the patients in the acupuncture group who did get angina attacks recovered 
much faster than the patients in the control group. 
Similar findings were reported in another study, this time in Sweden (116), where 21 
patients with stable effort angina pectoris were treated with acupuncture. All of the patients 
had a history of at least five anginal attacks per week despite intensive conventional medical 
treatment. They were given three acupuncture treatments per week which led to a 40% 
reduction in the number of anginal attacks and the researchers also observed that the 
patients were able to exercise for longer before the onset of pain. All the patients completed 
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a life quality questionnaire which confirmed that they all felt better as a result of the 
acupuncture treatment. The report concluded that acupuncture should be considered a 
beneficial treatment even for patients with severe, intensively treated angina pectoris. 
Other studies have come to the same conclusion (117,118) in the treatment of angina. In one 
research project at the Nanjing Medical College involving 267 patients, all suffering from 
angina pectoris, acupuncture treatment was shown to have a 93.3% success rate with no 
harmful side effects (119). 
There are some possible side effects and risks that could be involved in patients and depend 
completely upon the experience and expertise of the acupuncturist, but these are relatively 
less when compared to other forms of treatment. Some of the common acupuncture side 
effects or inconveniences experienced during or after acupuncture are: a regular sensation of 
warmth, tenderness, and tingling when the acupuncture needles reach the acupoint or 
trigger point, mild bruising and bleeding, temporary drop in blood pressure which may 
result in fatigue and rarely fainting, allergic reactions to stainless steel acupuncture needles, 
infections, and perforation of some of the vital organs by needles.  
Acupuncture is safe and complications are extremely rare and side effects, if any, are 
limited. There are a number of guidelines, however, which govern the use of particular 
acupuncture points. A precaution may be related to use in certain conditions, with 
particular techniques, or because of a points location, however, in some cases, practitioner 
may still use a point or technique even if it is listed as a precaution. 
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